Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lobel
Ilan Lobel, Cambridge, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110258052 | DYNAMIC MECHANISM FOR SELLING ONLINE ADVERTISING SPACE - A dynamic mechanism for selling online advertising space may involve computing allocation rules and pricing structures to align incentives of seller and bidders. Based on initial valuations reported by multiple advertisers, an advertising platform may compute entrance fees to be charged to each advertiser who enters into a contract for allocation of an advertising space over multiple allocation cycles. Based on an initial valuation reported by an advertiser, an advertising platform may compute an entrance fee to be charged to the advertiser as a lump sum or subscription fee, determine whether to allocate the advertising space to the advertiser in multiple successive allocation cycles, and compute allocation payment amounts to be charged to the advertiser when the advertiser receives allocations. Through appropriate construction of these computations, incentives may be aligned such that advertisers benefit from truthful reporting of valuations. | 10-20-2011 |
Leslie Lobel, Omer IL
| Patent application number | Description | Published |
|---|---|---|
| 20100291040 | VIRUS-LIKE PARTICLES FOR TREATMENT OF VIRAL INFECTIONS - The invention provides virus-like particles for treatment of viral infections based on the virus causing the infection. The virus-like particles comprise the virus recombinant proteins that form a capsid, recombinant virus membrane proteins attached to the capsid and vRNA packaged within said capsid. The vRNA is generated from a DNA sequence encoding a polypeptide capable of specifically binding to a constant region of a nonstructural protein of the virus that is essential for propagation of the virus. | 11-18-2010 |
Leslie Lobel, Forest Hills, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090093411 | Long-acting hormone and growth factor compositions and uses thereof - This invention provides VEGF-FSH compounds having increased serum half-lives relative to either native VEGF or FSH, in which both VEGF and FSH are biologically active. This invention also provides related compositions and methods for increasing fertility, egg production and spermatogenesis in a subject, as well as methods for increasing vascularization in a tissue, particularly in ovarian tissue. | 04-09-2009 |
Peter Lobel, Highland Park, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090022701 | Recombinant human CLN2 protein and methods of its production and use - The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering to the patient an amount of CLN2 protein effective to reduce or eliminate the symptoms caused by the deficiency in CLN2 protein. | 01-22-2009 |
| 20090075315 | NOVEL HUMAN LYSOSOMAL PROTEIN AND METHODS OF ITS USE - The gene associated and causative of classical late infantile neuronal ceroid lipofuscinosis (LINCL), CLN2, has been identified and characterized. The translation product of this gene is a novel protease and a deficiency in this activity results in LINCL. Identification of CLN2 will not only aid in the prevention of LINCL through genetic counseling but provides strategies and test systems for therapeutic intervention. In addition, further characterization of this previously unknown lysosomal enzyme may provide useful insights into other more common human neurodegenerative disorders. Finally, the utility of a general approach for determining the molecular bases for lysosomal disorders of unknown etiology has been demonstrated. | 03-19-2009 |
| 20110014172 | Recombinant Human CLN2 Protein and Methods of Its Production and Use - The present invention relates to a method for treating a patient having disorder characterized by a deficient amount of functional CLN2 protein in the affected cells, which comprises administering to the patient an amount of CLN2 protein effective to reduce or eliminate the symptoms caused by the deficiency in CLN2 protein. | 01-20-2011 |
| 20110166074 | CLN2 TREATMENT OF ALZHEIMER'S DISEASE - A method of treating Alzheimer's Disease may include administering to a subject in need of such treatment a CLN2 therapeutic having beta-amyloid degradation activity. | 07-07-2011 |
Stanley Lobel, Purchase, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090304902 | BUTCHERING PROCESSES FOR THE BEEF CLOD - A method for mass-production butchering of a chuck roll of beef includes: sectioning the beef clod into a first portion and a second portion substantially along a natural seam, the first portion comprising triceps brachii long head muscle and essentially being free of triceps brachii lateral head muscle, and the second portion comprising triceps brachii lateral head muscle and essentially being free of triceps brachii long head muscle; and sectioning the first portion generally with or parallel to the grain into a first set of separate portions. Another method for mass-production butchering of a beef clod may include: sectioning the beef clod into a first portion and a second portion substantially along a natural seam, the first portion comprising the teres major; and sectioning the first portion generally with or parallel to the grain into a first set of separate portions. | 12-10-2009 |
| 20100040760 | BUTCHERING PROCESSES FOR MEAT PRODUCTS - A method for mass-production butchering of a chuck roll of beef includes: sectioning the chuck roll anterior to and generally parallel to the first rib to separate a neck portion thereof from a remainder thereof; sectioning the remainder into a first portion and a second portion substantially along a natural seam, the first portion comprising rhomboideus, spinalis dorsi, and serratus ventralis muscles, and the second portion comprising multifidus dorsi, complexus, and longissimus dorsi muscles; sectioning the first portion to substantially remove the rhomboideus and the spinalis dorsi therefrom, leaving a denuded serratus ventralis; sectioning the serratus ventralis into a first set of separate portions. The method may further include: sectioning the second portion into a second set of separate portions, each separate portion in the second set including the multifidus dorsi, complexus, and longissimus dorsi muscles. | 02-18-2010 |
Wolfgang Lobel, Frankfurt DE
| Patent application number | Description | Published |
|---|---|---|
| 20100081511 | LONGITUDINAL SHAFT ASSEMBLY FOR A MOTOR VEHICLE - A longitudinal shaft assembly for a motor vehicle, comprising at least a first shaft and a second shaft, a ball-type constant velocity joint for connecting the first shaft to the second shaft and at least one central bearing for supporting the longitudinal shaft assembly with respect to a body of the motor vehicle. | 04-01-2010 |